Ticker name:ACOGAlpha Cognition Inc.

Country: US-Sector: Financial Services, Industry: Financial - Conglomerates

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Market Cap 193M

Last close 8.85$

Key metrics

Largest 11 companies In Financial - Conglomerates

# PositionTickerCompany NameMarket CapLast PriceAction
1PACSPACS Group, Inc.6.7B42.06$
2XXITwenty One Capital, Inc.3.1B5.57$
3MTAMetalla Royalty & Streaming Ltd.941M10.06$
4ENHAEnhanced Group Inc.577M1.46$
5RILYBRC Group Holdings, Inc.242M6.02$
6ACOGAlpha Cognition Inc.193M8.85$
7AVATAvalanche Treasury Corp39M0.881$
8FRTTFort Technology Inc14M0.9296$
9IRHOIron Horse Acquisition II Corp.010.06$
10MACIMelar Acquisition Corp. I/Cayman011.02$
11VACIViking Acquisition Corp I08.64$